Proteomics Fingerprints of Auy922 and 17-dmag Indicate Common Mechanisms of Action for Hsp90 Inhibitors
Hsp90 phase II candidate | Vernalis Research
![PDF] Ganetespib: research and clinical development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25a520c1fa08e8bd4ed3d065bbaddb983055dc78/2-Table1-1.png "PDF] Ganetespib: research and clinical development | Semantic Scholar")
PDF] Ganetespib: research and clinical development | Semantic Scholar
Luminespib - an overview | ScienceDirect Topics
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models | Breast Cancer Research | Full Text
The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth. - Abstract - Europe PMC
The Anticancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved among Structurally Diverse Hsp90 Inhibitors | Journal of Proteome Research
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer - ScienceDirect
Selected structures of Hsp90 inhibitors in clinical trials. | Download Scientific Diagram
HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice | ACS Chemical Neuroscience
Luminespib - Wikipedia
The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage | PLOS ONE
Exploring the inhibitory mechanism of resorcinylic isoxazole amine NVP- AUY922 towards the discovery of potential heat shock protein 90 (Hsp90) inhibitors - ScienceDirect
The HSP90 Inhibitor, AUY-922, Ameliorates the Development of Nitrogen Mustard-Induced Pulmonary Fibrosis and Lung Dysfunction in
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer | PGPM
In vitro sensitivity to NVP-AUY922. Forty-one cell lines with IC50 (A)... | Download Scientific Diagram
Luminespib (VER-52296) | HSP90 Inhibitor | MedChemExpress
Examples of Hsp90 N-terminal inhibitors in clinical trials. | Download Scientific Diagram
NVP-AUY922 inhibits downstream signaling of IGF-1Rβ and exerts... | Download Scientific Diagram
Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants* - Molecular & Cellular Proteomics
Luminespib (NVP-AUY922) | ≥99%(HPLC) | Selleck | HSP (HSP90) inhibitor
Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells | Anticancer Research
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer - Journal of Thoracic Oncology
Luminespib (VER-52296) | HSP90 Inhibitor | MedChemExpress
Hsp90 phase II candidate | Vernalis Research
